Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia.

× No keyword cloud information.

13 in total

1. IOM committee members respond to Endocrine Society vitamin D guideline.

Authors: Clifford J Rosen; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; JoAnn E Manson; Susan T Mayne; A Catharine Ross; Sue A Shapses; Christine L Taylor
Journal: J Clin Endocrinol Metab Date: 2012-03-22 Impact factor: 5.958

2. Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies.

Authors: Jennifer L Kelly; Gilles Salles; Bryan Goldman; Richard I Fisher; Pauline Brice; Oliver Press; Olivier Casasnovas; David G Maloney; Pierre Soubeyran; Lisa Rimsza; Corinne Haioun; Luc Xerri; Michael LeBlanc; Hervé Tilly; Jonathan W Friedberg
Journal: J Clin Oncol Date: 2015-03-30 Impact factor: 44.544

3. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958

Review 4. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence.

Authors: Pawel Pludowski; Michael F Holick; Stefan Pilz; Carol L Wagner; Bruce W Hollis; William B Grant; Yehuda Shoenfeld; Elisabeth Lerchbaum; David J Llewellyn; Katharina Kienreich; Maya Soni
Journal: Autoimmun Rev Date: 2013-03-28 Impact factor: 9.754

1. Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters.

Authors: Mervat M Omran; Samia A Shouman; Raafat Abdelfattah; Heba S Moussa; Nadia A Thabet; Marwa S Hamza
Journal: Curr Ther Res Clin Exp Date: 2022-09-01

1 in total

Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia.

1. IOM committee members respond to Endocrine Society vitamin D guideline.

2. Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies.

3. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Review 4. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence.

Review 5. The role of vitamin D in cancer prevention and treatment.

Review 6. Tyrosine Kinase Inhibitors in Ph+ Chronic Myeloid Leukemia Therapy: a Review.

7. Abundant sunshine and vitamin D deficiency.

8. [Intestinal bleeding in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors].

9. IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia.

10. Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes.

1. Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters.